Skip to content

Recovering From COVID-19

Recovering From COVID-19: Community-based Remote Monitoring in COVID-19 (SARS-CoV 2) Cases: The OVER-COVID Study

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05302960
Acronym
OVER-COVID
Enrollment
0
Registered
2022-03-31
Start date
2021-11-30
Completion date
2024-04-08
Last updated
2024-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS CoV 2 Infection

Keywords

monitoring, ambulatory, vital signs, remote monitoring

Brief summary

Following the success of pilot data trialling a virtual community-based remote monitoring model, using Bluetooth enabled pulse oximeters, which demonstrated a saving of 300 bed spaces over a three week period,9 a nationwide expansion is set to be implemented through NHS Digital. Participants who were on the virtual wards approximately 12 weeks after their admission and those referred to long-COVID outpatient clinics will be approached. There is a particular lack of understanding as to whether post-COVID syndrome constitutes a singular disease process. It has been suggested that the post-COVID syndrome may be characterised into either an acute or chronic subtype, depending on whether symptoms extend beyond 12 weeks following initial diagnosis.7,10 However, it is not currently understood as to whether chronic post-COVID is either an extension of acute post-COVID or is a separate disease subtype that carries a distinct risk profile. However, there remains a paucity in the literature depicting the recovery experience, risk factors for the development of post-COVID syndrome, management strategies, and qualitative experiences. This study aims to address these gaps

Interventions

DEVICEFitbit

The use of Fitbit sensors to see if activity levels can be improved to track recovery from COVID

Sponsors

Imperial College London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Aged 18 years or over. * Able to provide written consent.

Exclusion criteria

* Any participants that withdraw their consent. * Any form of psychiatric disorder or a condition that, in the opinion of the investigator, may hinder communication with the research team. * Inability to cooperate or communicate with the research team.

Design outcomes

Primary

MeasureTime frameDescription
Step countup to 1 yearstep count recorded from Fitbit devices

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026